Theravance Biopharma: Of This Report, Including The Communications Attached As Exhibits 99.2 And 99.3, Is Furnished Pursuant To Item 7.01 Of Form8kand Shall Not Be Deemed “filed” For The Purposes Of Section18 Of The Securities Exchange Act, As Amended (the “, Other Events, Financial Statements And Exhibits

Mostra articolo completo

Questa funzionalità è disponibile solo per gli utenti registrati

• Nome completo dell'emittente
  Theravance Biopharma, Inc.
• Paese di registrazione
  USA
• Settore industriale
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***